Zacks.com on MSN4 天
PODD Stock to Gain From Launch of Omnipod 5 With Abbott's CGM in US
Insulet's Omnipod 5 System is now compatible with Abbott's FreeStyle Libre 2 Plus Sensor in the United States.
Insulet Corporation: Significant Opportunities, Significant Threats - I'm On The Sidelines
Insulet's financials are robust, with rising revenues, margins, and a strong cash position. Click here to read an analysis of ...
Zacks.com on MSN1 天
If You Invested $1000 in Insulet a Decade Ago, This is How Much It'd Be Worth Now
For most investors, how much a stock's price changes over time is important. Not only can it impact your investment portfolio, but it can also help you compare investment results across sectors and ...
HME News5 天
Insulet’s Omnipod integrates with Libre
ACTON, Mass. – Insulet’s Omnipod 5 Automated Insulin Delivery System is now compatible with Abbott’s FreeStyle Libre 2 Plus continuous glucose monitoring sensor in the U.S. “We are excited to announce ...
Insider Monkey5 天
Here’s Why DexCom (DXCM) Declined In Q3
Carillon Eagle Mid Cap Growth Fund highlighted stocks like DexCom, Inc. (NASDAQ:DXCM), in the third quarter 2024 investor letter. DexCom, Inc. (NASDAQ:DXCM) is a medical device company that ...